N-Acetyltransferase-2 and Medical History in Bladder Cancer Cases with a Suspected Occupational Disease (BK 1301) in Germany
Authors:
- 3 June 2008
- journal article
- research article
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part A
- Vol. 71 (13-14) , 906-910
Abstract
In 187 bladder cancer cases reported to the employers' liability insurance association in Germany as suspected cases of an occupational disease produced by aromatic amines, N‐ acetyltransferase-2 (NAT2) activity status, occupational exposure data, period of latency, and clinical parameters were determined. In 83 out of 187 cases surveyed within the period 1991–1999, the NAT2 acetylator status was investigated by determining the molar ratio of an acetylated and a nonacetylated caffeine metabolite in urine (phenotyping) and/or by NAT2 genotyping according to standard polymerase chain reaction (PCR) protocol. The proportion of slow NAT2 acetylators in the surveyed 83 bladder cancer cases was 67%. In the entire group of surveyed 187 cases, mean duration of exposure was 17.6 yr and mean period of latency was 34.7 yr. Occupational exposures to potential bladder carcinogens were observed in 73 occupations, including chemical industry (25%), and occupations as a painter and/or varnisher (23%) were most often encountered. In 12% of the surveyed bladder cancer cases, a second primary malignancy was observed. The NAT2 distribution observed in the 83 cases is comparable to the proportion in 40 occupationally exposed bladder cancer cases in a Department of Urology located close to a former German production site of benzidine-based azo dyes, but higher than in most studies involving NAT2 genetic status in bladder cancer cases.Keywords
This publication has 11 references indexed in Scilit:
- Hemoglobin adducts of the human bladder carcinogen o-toluidine after treatment with the local anesthetic prilocaineToxicology, 2007
- NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analysesThe Lancet, 2005
- Carcinogenicity of azo colorants: influence of solubility and bioavailabilityToxicology Letters, 2004
- The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: a review considering ethnic differencesToxicology Letters, 2002
- Review Article: Compendium of Chemical Carcinogens by Target Organ: Results of Chronic Bioassays in Rats, Mice, Hamsters, Dogs, and MonkeysToxicologic Pathology, 2001
- Aromatic Amines, Nitroarenes, and Heterocyclic Aromatic Amines1999
- Occupational history and genetic N-acetyltransferase polymorphism of urothelial cancer patients in Leverkusen, GermanyScandinavian Journal of Work, Environment & Health, 1996
- ROLE OF N-ACETYLTRANSFERASE PHENOTYPES IN BLADDER CARCINOGENESIS: A PHARMACOGENETIC EPIDEMIOLOGICAL APPROACH TO BLADDER CANCERThe Lancet, 1982
- Multiple primary cancers following exposure to benzidine and beta‐naphthylamineAmerican Journal of Industrial Medicine, 1982
- The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States TodayJNCI: Journal of the National Cancer Institute, 1981